The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Open accessAbstract
BACKGROUND: Accurate, rapid detection of tuberculosis (TB) and TB drug resistance is critical for improving patient care and decreasing TB transmission. Xpert® MTB/RIF assay is an automated test that can detect both TB and rifampicin resistance, generally within two hours after starting the test, with minimal hands-on technical time. The World Health Organization (WHO) issued initial recommendations on Xpert® MTB/RIF in early 2011. A Cochrane Review on the diagnostic accuracy of Xpert® MTB/RIF for pulmonary TB and rifampicin resistance was published January 2013. We performed this updated Cochrane Review as part of a WHO process to develop updated guidelines on the use of the test. OBJECTIVES: To assess the diagnostic accuracy of Xpert® MTB/RIF for pulmonary TB (TB detection), where Xpert® MTB/RIF was used as both an initial test replacing microscopy and an add-on test following a negative smear microscopy result.To assess the diagnostic accuracy of Xpert® MTB/RIF for rifampicin resistance detection, where Xpert® MTB/RIF was used as the initial test replacing culture-based drug susceptibility testing (DST).The populations of interest were adults presumed to have pulmonary, rifampicin-resistant or multidrug-resistant TB (MDR-TB), with or without HIV infection. The settings of interest were intermediate- and peripheral-level laboratories. The latter may be associated with primary health care facilities. SEARCH METHODS: We searched for publications in any language up to 7 February 2013 in the following databases: Cochrane Infectious Diseases Group Specialized Register; MEDLINE; EMBASE; ISI Web of Knowledge; MEDION; LILACS; BIOSIS; and SCOPUS. We also searched the metaRegister of Controlled Trials (mRCT) and the search portal of the WHO International Clinical Trials Registry Platform to identify ongoing trials. SELECTION CRITERIA: We included randomized controlled trials, cross-sectional studies, and cohort studies using respiratory specimens that allowed for extraction of data evaluating Xpert® MTB/RIF against the reference standard. We excluded gastric fluid specimens. The reference standard for TB was culture and for rifampicin resistance was phenotypic culture-based DST. DATA COLLECTION AND ANALYSIS: For each study, two review authors independently extracted data using a standardized form. When possible, we extracted data for subgroups by smear and HIV status. We assessed the quality of studies using QUADAS-2 and carried out meta-analyses to estimate pooled sensitivity and specificity of Xpert® MTB/RIF separately for TB detection and rifampicin resistance detection. For TB detection, we performed the majority of analyses using a bivariate random-effects model and compared the sensitivity of Xpert® MTB/RIF and smear microscopy against culture as reference standard. For rifampicin resistance detection, we undertook univariate meta-analyses for sensitivity and specificity separately to include studies in which no rifampicin resistance was detected. MAIN RESULTS: We included 27 unique studies (integrating nine new studies) involving 9557 participants. Sixteen studies (59%) were performed in low- or middle-income countries. For all QUADAS-2 domains, most studies were at low risk of bias and low concern regarding applicability.As an initial test replacing smear microscopy, Xpert® MTB/RIF pooled sensitivity was 89% [95% Credible Interval (CrI) 85% to 92%] and pooled specificity 99% (95% CrI 98% to 99%), (22 studies, 8998 participants: 2953 confirmed TB, 6045 non-TB).As an add-on test following a negative smear microscopy result, Xpert®MTB/RIF pooled sensitivity was 67% (95% CrI 60% to 74%) and pooled specificity 99% (95% CrI 98% to 99%; 21 studies, 6950 participants).For smear-positive, culture-positive TB, Xpert® MTB/RIF pooled sensitivity was 98% (95% CrI 97% to 99%; 21 studies, 1936 participants).For people with HIV infection, Xpert® MTB/RIF pooled sensitivity was 79% (95% CrI 70% to 86%; 7 studies, 1789 participants), and for people without HIV infection, it was 86% (95% CrI 76% to 92%; 7 studies, 1470 participants). Comparison with smear microscopy In comparison with smear microscopy, Xpert® MTB/RIF increased TB detection among culture-confirmed cases by 23% (95% CrI 15% to 32%; 21 studies, 8880 participants).For TB detection, if pooled sensitivity estimates for Xpert® MTB/RIF and smear microscopy are applied to a hypothetical cohort of 1000 patients where 10% of those with symptoms have TB, Xpert® MTB/RIF will diagnose 88 cases and miss 12 cases, whereas sputum microscopy will diagnose 65 cases and miss 35 cases. Rifampicin resistance For rifampicin resistance detection, Xpert® MTB/RIF pooled sensitivity was 95% (95% CrI 90% to 97%; 17 studies, 555 rifampicin resistance positives) and pooled specificity was 98% (95% CrI 97% to 99%; 24 studies, 2411 rifampicin resistance negatives). Among 180 specimens with nontuberculous mycobacteria (NTM), Xpert® MTB/RIF was positive in only one specimen that grew NTM (14 s
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility
Lunn, D. J., Thomas, A., Best, N., & Spiegelhalter, D. (2000) · Statistics and Computing · doi:10.1023/a:1008929526011 · Cited by 5,368
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Norussis, H. (1993) · Medical Entomology and Zoology · Cited by 2,704
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Self-citationThe Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Self-citationR Development Core Team (2010): R: A language and environment for statistical computing
Dalgaard, P. (2010) · Cited by 934
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
Self-citationFluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review
Steingart, K. R., Henry, M., Ng, V., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70578-3 · Cited by 798
Self-citationSteingart, K. R., Ng, V., Henry, M., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70602-8 · Cited by 573
Self-citationGetahun, H., Harrington, M., O'Brien, R., & Nunn, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60284-0 · Cited by 550
The specific inhibition of the DNA-directed RNA synthesis by rifamycin
Hartmann, G., Honikel, K. O., Knüsel, F., & Nüesch, J. (1967) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(67)90147-5 · Cited by 519
Lawn, S. D., & Nicol, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.84 · Cited by 486
Evaluation of the analytical performance of the Xpert MTB/RIF assay
Blakemore, R., Story, E., Helb, D., Kop, J., Banada, P., Owens, M. R., Chakravorty, S., Jones, M., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-10 · Cited by 485
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Theron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., Bara, W., Mungofa, S., Pai, M., Hoelscher, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62073-5 · Cited by 433
Self-citationRapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413
Self-citationFalzon, D., Jaramillo, E., & Schünemann, H. J. (2011) · European Respiratory Journal · doi:10.1183/13993003/erj.38.suppl_55.393 · Cited by 393
Wright, A., Zignol, M., Van Deun, A., Falzon, D., Gerdes, S. R., Feldman, K., Hoffner, S., Drobniewski, F., Barrera, L., van Soolingen, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60331-7 · Cited by 385
Zeka, A. N., Tasbakan, S., & Cavusoglu, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05434-11 · Cited by 362
Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?
Vadwai, V., Boehme, C., Nabeta, P., Shetty, A., Alland, D., & Rodrigues, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02319-10 · Cited by 357
Self-citationBoehme, C. C., Nabeta, P., Henostroza, G., Raqib, R., Rahim, Z., Gerhardt, M., Sanga, E., Hoelscher, M., Notomi, T., Hase, T., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-06 · Cited by 341
Self-citationGenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Ling, D. I., Zwerling, A. A., & Pai, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00061808 · Cited by 340
Self-citationNicol, M. P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Boehme, C. C., Zemanay, W., & Zar, H. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70167-0 · Cited by 338
Self-citationNo role for quality scores in systematic reviews of diagnostic accuracy studies
Whiting, P., Harbord, R., & Kleijnen, J. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-19 · Cited by 337
Analysing and Presenting Results
Macaskill, P., Gatsonis, C., Deeks, J. J., Harbord, R., & Takwoingi, Y. (2010) · Bristol Research (University of Bristol) · Cited by 337
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
Vassall, A., van Kampen, S., Sohn, H., Michael, J. S., John, K. R., den Boon, S., Davis, J. L., Whitelaw, A., Nicol, M. P., Gler, M. T., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001120 · Cited by 313
Self-citationTheron, G., Peter, J., van Zyl-Smit, R., Mishra, H., Streicher, E., Murray, S., Dawson, R., Whitelaw, A., Hoelscher, M., Sharma, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0056oc · Cited by 311
Self-citationFacing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era
Perkins, M. D., & Cunningham, J. (2007) · The Journal of Infectious Diseases · doi:10.1086/518656 · Cited by 300
Lawn, S. D., Kerkhoff, A. D., Vogt, M., & Wood, R. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70251-1 · Cited by 300
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010
Zignol, M., van Gemert, W., Falzon, D., Sismanidis, C., Glaziou, P., Floyd, K., & Raviglione, M. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.092585 · Cited by 295
Lawn, S. D., Brooks, S. V., Kranzer, K., Nicol, M. P., Whitelaw, A., Vogt, M., Bekker, L.-G., & Wood, R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001067 · Cited by 278
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
(2009) · JAMA · doi:10.1001/jama.2009.148 · Cited by 268
Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., Deng, S., & Chen, M. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.02.012 · Cited by 267
Toman's Tuberculosis: Case Detection, Treatment and Monitoring: Questions and Answers
Frieden, T. R. (2004) · Cited by 264
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Self-citationMarlowe, E. M., Novak-Weekley, S. M., Cumpio, J., Sharp, S. E., Momeny, M. A., Babst, A., Carlson, J. S., Kawamura, M., & Pandori, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02214-10 · Cited by 253
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Van Deun, A., Aung, K. J. M., Bola, V., Lebeke, R., Hossain, M. A., de Rijk, W. B., Rigouts, L., Gumusboga, A., Torrea, G., & de Jong, B. C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00553-13 · Cited by 241
Ling, D. I., Flores, L. L., Riley, L. W., & Pai, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001536 · Cited by 222
Self-citationTuberculosis Diagnosis — Time for a Game Change
Small, P. M., & Pai, M. (2010) · New England Journal of Medicine · doi:10.1056/nejme1008496 · Cited by 196
Self-citationMycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
Van Deun, A., Barrera, L., Bastian, I., Fattorini, L., Hoffmann, H., Kam, K. M., Rigouts, L., Rüsch-Gerdes, S., & Wright, A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01209-09 · Cited by 186
Flores, L. L., Pai, M., Colford, J. M., & Riley, L. W. (2005) · BMC Microbiology · doi:10.1186/1471-2180-5-55 · Cited by 181
Self-citationArmand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02157-10 · Cited by 179
Drug-Resistant Tuberculosis—Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs
Zumla, A., Abubakar, I., Raviglione, M., Hoelscher, M., Ditiu, L., Mchugh, T. D., Squire, S. B., Cox, H., Ford, N., McNerney, R., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir858 · Cited by 175
GeneXpert—A Game-Changer for Tuberculosis Control?
Evans, C. A. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001064 · Cited by 172
Scott, L. E., McCarthy, K., Gous, N., Nduna, M., Van Rie, A., Sanne, I., Venter, W. F., Duse, A., & Stevens, W. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001061 · Cited by 171
Rapid Molecular Diagnosis of Pulmonary Tuberculosis in Children Using Nasopharyngeal Specimens
Zar, H. J., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Allen, V., Boehme, C. C., Zemanay, W., & Nicol, M. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis598 · Cited by 165
Self-citationMoure, R., Muñoz, L., Torres, M., Santin, M., Martín, R., & Alcaide, F. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01831-10 · Cited by 165
Greco, S., Girardi, E., Navarra, A., & Saltini, C. (2006) · Thorax · doi:10.1136/thx.2005.054908 · Cited by 162
Rachow, A., Zumla, A., Heinrich, N., Rojas-Ponce, G., Mtafya, B., Reither, K., Ntinginya, E. N., O'Grady, J., Huggett, J., Dheda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020458 · Cited by 160
Self-citationNon-Tuberculous Mycobacteria in TB-Endemic Countries: Are We Neglecting the Danger?
Gopinath, K., & Singh, S. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000615 · Cited by 159
Rie, A. V., Page-Shipp, L., Scott, L., Sanne, I., & Stevens, W. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.67 · Cited by 159
The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
Meyer-Rath, G., Schnippel, K., Long, L., MacLeod, W., Sanne, I., Stevens, W., Pillay, S., Pillay, Y., & Rosen, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036966 · Cited by 158
Banada, P. P., Sivasubramani, S. K., Blakemore, R., Boehme, C. C., Perkins, M. D., Fennelly, K. P., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01053-10 · Cited by 156
Self-citationRachow, A., Clowes, P., Saathoff, E., Mtafya, B., Michael, E., Ntinginya, E. N., Kowour, D., Rojas-Ponce, G., Kroidl, A., Maboko, L., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis190 · Cited by 154
Ioannidis, P., Papaventsis, D. C., Karabela, S., Nikolaou, S., Panagi, M., Raftopoulou, E., Konstantinidou, E., Μαρίνου, Ι., & Kanavaki, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00718-11 · Cited by 152
Bates, M., O’Grady, J., Maeurer, M. J., Tembo, J. M., Chilukutu, L., Chabala, C., Kasonde, R., Mulota, P., Mzyece, J., Chomba, M., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70245-1 · Cited by 152
Comparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary Tuberculosis
Causse, M., Ruiz, P., Gutiérrez-Aroca, J. B., & Casal, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00491-11 · Cited by 145
Martin, A., Portaels, F., & Palomino, J. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl477 · Cited by 143
Xpert MTB/RIF Assay for Diagnosis of Pleural Tuberculosis
Friedrich, S. O., von Groote-Bidlingmaier, F., & Diacon, A. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05454-11 · Cited by 126
Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden
van Zyl-Smit, R. N., Binder, A. B., Meldau, R., Mishra, H. K., Semple, P. L., Theron, G., Peter, J., Whitelaw, A. C., Sharma, S. K., Warren, R. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028815 · Cited by 126
Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
Trébucq, A., Enarson, D. A., Chiang, C., Deun, A. V., Harries, A. D., Boillot, F., Detjen, A., Fujiwara, P. I., Graham, S. M., Monedero, I., et al. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0392 · Cited by 125
Ligthelm, L. J., Nicol, M. P., Hoek, K. G. P., Jacobson, R., van Helden, P. D., Marais, B. J., Warren, R. M., & Wright, C. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01310-11 · Cited by 123
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0536oc · Cited by 118
Self-citationBarnard, M., van Pittius, N. C. G., van Helden, P. D., Bosman, M. E., Coetzee, G. J., & Warren, R. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01958-12 · Cited by 116
Pantoja, A., Fitzpatrick, C., Vassall, A., Weyer, K., & Floyd, K. (2012) · European Respiratory Journal · doi:10.1183/09031936.00147912 · Cited by 108
Evaluation of Nucleic Acid Amplification Tests in the Absence of a Perfect Gold-Standard Test
Hadgu, A., Dendukuri, N., & Hilden, J. (2005) · Epidemiology · doi:10.1097/01.ede.0000173042.07579.17 · Cited by 107
Self-citationWilliamson, D. A., Roberts, S., Bower, J. E., Vaughan, R., Newton, S., Lowe, O., Lewis, C. A., & Freeman, J. T. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0178 · Cited by 106
Alvarez‐Uria, G., Azcona, J. M., Midde, M., Naik, P. K., Reddy, S., & Reddy, R. (2012) · Tuberculosis Research and Treatment · doi:10.1155/2012/932862 · Cited by 104
Martin, A., Panaiotov, S., Portaels, F., Hoffner, S., Palomino, J. C., & Ängeby, K. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn139 · Cited by 104
Peter, J., Theron, G., Muchinga, T. E., Govender, U., & Dheda, K. U. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039966 · Cited by 93
Moure, R., Martín, R., & Alcaide, F. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06467-11 · Cited by 90
Yoon, C., Cattamanchi, A., Davis, J. L., Worodria, W. O., den Boon, S., Kalema, N., Katagira, W., Kaswabuli, S., Miller, C. R., Andama, A. O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048599 · Cited by 90
Chu, H., Chen, S., & Louis, T. A. (2009) · Journal of the American Statistical Association · doi:10.1198/jasa.2009.0017 · Cited by 87
Hanrahan, C. F., Selibas, K., Deery, C. B., Dansey, H., Clouse, K., Bassett, J., Scott, L. E., Stevens, W. S., Sanne, I., & Rie, A. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065421 · Cited by 85
Raizada, N., Sachdeva, K. S., Sreenivas, A., Vadera, B., Gupta, R. S., Parmar, M., Kulsange, S., Babre, A., Thakur, R., Gray, C. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089301 · Cited by 83
Self-citationAndrews, J. R., Lawn, S. D., Rusu, C. A., Wood, R., Noubary, F., Bender, M. A., Horsburgh, C. R., Losina, E., Freedberg, K. A., & Walensky, R. P. (2012) · AIDS · doi:10.1097/qad.0b013e3283522d47 · Cited by 83
Williamson, D. A., Basu, I., Bower, J. E., Freeman, J. T., Henderson, G., & Roberts, S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.06.013 · Cited by 81
Malbruny, B., Le Marrec, G., Courageux, K., Leclercq, R., & Cattoir, V. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0497 · Cited by 79
Miller, M. B., Popowitch, E. B., Backlund, M. G., & Ager, E. P. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05212-11 · Cited by 77
Drobniewski, F. A., Nikolayevskyy, V., Balabanova, Y., Bang, D., & Papaventsis, D. C. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0180 · Cited by 76
Wood, R., Racow, K., Bekker, L., Middelkoop, K., Vogt, M., Kreiswirth, B. N., & Lawn, S. D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-47 · Cited by 75
O’Grady, J., Bates, M., Chilukutu, L., Mzyece, J., Cheelo, B., Chilufya, M., Mukonda, L., Mumba, M., Tembo, J. M., Chomba, M., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis631 · Cited by 74
Lawn, S. D., Kerkhoff, A. D., Vogt, M., Ghebrekristos, Y. T., Whitelaw, A. C., & Wood, R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1039 · Cited by 73
International Standards for Tuberculosis Care (ISTC)
(2009) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10992_67 · Cited by 72
Clouse, K., Page‐Shipp, L., Dansey, H., et al. (2012) · South African Medical Journal · doi:10.7196/samj.5851 · Cited by 71
Early tuberculosis treatment monitoring by Xpert® MTB/RIF: Figure 1–
Miotto, P., Bigoni, S., Migliori, G. B., Matteelli, A., & Cirillo, D. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00124711 · Cited by 68
Boyles, T. H., Hughes, J. A., Cox, V., Burton, R., Meintjes, G., & Mendelson, M. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0853 · Cited by 66
Tuberculosis assays: past, present and future
Chegou, N. N., Hoek, K. G. P., Kriel, M., Warren, R. M., Victor, T. C., & Walzl, G. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.23 · Cited by 66
Theron, G., Pooran, A., Peter, J., van Zyl-Smit, R. N., Mishra, H. K., Meldau, R., Calligaro, G., Allwood, B., Sharma, S. K., Dawson, R., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00145511 · Cited by 66
Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
Dorman, S. E., Chihota, V. N., Lewis, J. J., Shah, M., Clark, D., Grant, A. D., Churchyard, G., & Fielding, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043307 · Cited by 66
Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
Dowdy, D. W., Cattamanchi, A., Steingart, K. R., & Pai, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001063 · Cited by 63
Self-citationEvaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
Nhu, N. T. Q., Hà, Đ. T. M., Anh, N. Đ., Thu, D. D. A., Duong, T. N., Quang, N. D., Lan, N. T. N., Quyet, T. V., Tuyen, N. T. B., Ha, V. T., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-31 · Cited by 63
Schnippel, K., Meyer‐Rath, G., Long, L. C., MacLeod, W., Sanne, I., Stevens, W. S., & Rosen, S. B. (2012) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2012.03028.x · Cited by 57
Lawn, S. D., Kerkhoff, A. D., Vogt, M., & Wood, R. (2012) · AIDS · doi:10.1097/qad.0b013e3283553685 · Cited by 55
Teo, J. W. P., Jureen, R., Chiang, D., Chan, D. S. G., & Lin, R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00211-11 · Cited by 53
Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics?
Denkinger, C. M., Nicolau, I. A., Ramsay, A., Chedore, P., & Pai, M. (2013) · European Respiratory Journal · doi:10.1183/09031936.00081113 · Cited by 52
Self-citationLawn, S. D., Kerkhoff, A. D., Vogt, M., & Wood, R. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318258c6af · Cited by 51
Al-Ateah, S. M., Al-Dowaidi, M. M., & El-Khizzi, N. A. (2012) · Saudi Medical Journal · doi:10.15537/1658-3175.5638 · Cited by 47
Carriquiry, G., Otero, L., González-Lagos, E., Zamudio, C., Sánchez, E., Nabeta, P., Campos, M. A. L., Echevarria, J. I., Seas, C., & Gotuzzo, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044626 · Cited by 44
Abimbola, T. O., Marston, B. J., Date, A. A., Blandford, J. M., Sangrujee, N., & Wiktor, S. Z. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318246538f · Cited by 44
Theron, G., Pinto, L., Peter, J., Mishra, H. K., Mishra, H. K., van Zyl-Smit, R. N., Sharma, S. K., & Dheda, K. U. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir824 · Cited by 42
Friedrich, S. O., Venter, A., Kayigire, X. A., Dawson, R., Donald, P. R., & Diacon, A. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00138-11 · Cited by 41
Rie, A. V., Page‐Shipp, L., Hanrahan, C. F., Schnippel, K., Dansey, H., Bassett, J., Clouse, K., Scott, L. E., Stevens, W. S., & Sanne, I. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0392 · Cited by 40
Clinical Research and Development of Tuberculosis Diagnostics: Moving From Silos to Synergy
Nahid, P., Kim, P. S., Evans, C. A., Alland, D., Barer, M. R., Diefenbach, J., Ellner, J. J., Hafner, R., HAMILTON, C. D., Iademarco, M. F., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis194 · Cited by 38
Confronting Multidrug-Resistant Tuberculosis
Chaisson, R. E., & Nuermberger, E. L. (2012) · New England Journal of Medicine · doi:10.1056/nejme1204478 · Cited by 34
Bowles, E., Freyee, B., van Ingen, J., Mulder, B., Boeree, M. J., & van Soolingen, D. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0574 · Cited by 33
Scott, L. E., Gous, N. M., Cunningham, B., Kana, B. D., Perovic, O., Erasmus, L., Coetzee, G. J., KOORNHOF, H. J., & Stevens, W. S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05167-11 · Cited by 32
Hanif, S. N. M., Eldeen, H. S., Ahmad, S., & Mokaddas, E. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0394 · Cited by 29
Ntinginya, E. N., Squire, S. B., Millington, K. A., Mtafya, B., Saathoff, E., Heinrich, N., Rojas-Ponce, G., Kowuor, D. O., Maboko, L., Reither, K., et al. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0127 · Cited by 29
Adjusting for verification bias in diagnostic test evaluation: A Bayesian approach
Buzoianu, M., & Kadane, J. B. (2007) · Statistics in Medicine · doi:10.1002/sim.3099 · Cited by 29
Taylor, N., Gaur, R. L., Baron, E. J., & Banaei, N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01012-12 · Cited by 28
Kurbatova, E. V., Kaminski, D. A., Ерохин, В. В., Volchenkov, G. V., Andreevskaya, S. N., Черноусова, Л. Н., Demikhova, O. V., Ershova, J. V., Kaunetis, N. V., Kuznetsova, T. A., et al. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1798-0 · Cited by 27
The Urgent Need for New Diagnostics for Symptomatic Tuberculosis in Children
Cuevas, L. E. (2010) · The Indian Journal of Pediatrics · doi:10.1007/s12098-010-0354-0 · Cited by 26
Kirwan, D. E., Cárdenas, M. K., & Gilman, R. H. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0107 · Cited by 24
Detecting Drug-Resistant Tuberculosis: The Importance of Rapid Testing
Hoek, K. G. P., Rie, A. V., van Helden, P. D., Warren, R. M., & Victor, T. C. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256410 · Cited by 23
Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile
Balcells, M. E., García, P., Leonardo Chanqueo, C., Bahamondes, L. G., Lasso, M., Gallardo, A. M. R., & Cifuentes, L. I. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0156 · Cited by 21
Rapid molecular detection of tuberculosis
Zbinden, A. C., Keller, P. M., & Bloemberg, G. V. (2011) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-46070 · Cited by 18
Kim, S. Y., Kim, H., Kim, S. Y., Ra, E. K., Joo, S.-I., Shin, S., Seong, M., Yoo, C.-G., Kim, E.-C., & Park, S. S. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0602 · Cited by 17
GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?
Muñoz, L., Moure, R., Porta, N., Fernández, L. G., Guerra, R., Alcaide, F., & Santín, M. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.11.011 · Cited by 15
Xpert MTB/RIF test for tuberculosis
Theron, G., Peter, J., & Dheda, K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61242-7 · Cited by 14
(2012) · PubMed · Cited by 14
Çiftçi, İ. H., Aslan, M. H., & Aşık, G. (2011) · PubMed · Cited by 13
Xpert TB diagnostic highlights gap in point-of-care pipeline
Morris, K. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70231-0 · Cited by 8
Should Xpert® MTB/RIF be rolled out in low-income countries? [Correspondence]
Peters, D. H., Theron, G., Peter, J., & Dheda, K. U. J. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0034 · Cited by 7
In reply to ‘Should Xpert® MTB/RIF be rolled out in low-income countries?’ [Correspondence]
Trébucq, A., Harries, A. D., & Rieder, H. L. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0034-2 · Cited by 6
Xpert MTB/RIF test for tuberculosis
Ferrara, G., O’Grady, J., Zumla, A. I., & Maeurer, M. J. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61244-0 · Cited by 5
Characteristics of Xpert MTB/RIF-Negative Patients With Pulmonary Tuberculosis
Theron, G., Peter, J., & Dheda, K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis465 · Cited by 5
Melzer, M. (2010) · BMJ Evidence-Based Medicine · doi:10.1136/ebm1163 · Cited by 4
Xpert MTB/RIF test for tuberculosis – Authors' reply
Perkins, M. D., Alland, D., Nicol, M. P., Nabeta, P., & Boehme, C. C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61245-2 · Cited by 3
Self-citationThe new face of tuberculosis diagnosis
Morris, K. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70268-7 · Cited by 2
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Self-citationDiagnostic point-of-care tests in resource-limited settings
Drain, P. K., Hyle, E. P., Noubary, F., Freedberg, K. A., Wilson, D., Bishai, W. R., Rodriguez, W., & Bassett, I. V. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70250-0 · Cited by 744
Dorman, S. E., Schumacher, S. G., Alland, D., Nabeta, P., Armstrong, D. T., King, B., Hall, S. L., Chakravorty, S., Cirillo, D. M., Tukvadze, N., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30691-6 · Cited by 689
Self-citationDheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Chakravorty, S., Simmons, A. M., Rowneki, M., Parmar, H., Cao, Y., Ryan, J., Banada, P. P., Deshpande, S., Shenai, S., Gall, A., et al. (2017) · mBio · doi:10.1128/mbio.00812-17 · Cited by 668
Metadata
- Authors
- Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-01-21
- Issue
- 1
- Pages
- CD009593-CD009593
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1606105143
- Cited by
- 1,102
- References
- 136
- FWCI
- 96.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.